CylembIO (stylized) — 2313920
Application number
2313920
Registration number
TMA1359520
Type(s)
Design
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2024-03-06
Registered
2025-11-14
Registration Expiry Date
2035-11-14
Registered Owner
IO Biotech ApS
Ole Maaløes Vej 3
2200 Copenhagen N,
DENMARK
Agent
SMART & BIGGAR LP
Scotia Plaza, 40 King Street West
40th Floor
Toronto
ONTARIO M5H3Y2
Address for Service
BERESKIN & PARR LLP/S.E.N.C.R.L., S.R.L.
SCOTIA PLAZA
40 KING STREET WEST, 40th Floor
Toronto
ONTARIO M5H3Y2
Documents
Index headings
- CYLEMBIO
- CYLEMB IO
- I
Vienna information (Code & Description)
- 24.17.1
- Punctuation marks
- A 24.17.2
- Dots
- 26.1.1
- Circles
- A 26.1.3
- One circle or ellipse
- 26.1.6
- Several circles or ellipses, juxtaposed, tangential or intersecting
- A 26.1.24
- Circles or ellipses with dark surfaces or parts of surfaces
- A 26.1.26
- Circles or ellipses with cutout areas
- 27.5.1
- Letters presenting a special form of writing
- A 27.5.7
- Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical preparations for the prevention and treatment of musculoskeletal, cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, and dermatological diseases; pharmaceutical drugs and pharmaceutical substances for the prevention and treatment of, musculoskeletal, cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, and dermatological diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of musculoskeletal, cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, and dermatological diseases; human vaccines.
Claims
- Priority Filing Date: February 05, 2024, Country or Office: UNITED KINGDOM, Application No. 00004011185 in association with the same kind of goods
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2024-03-06 | ||
| Created | 2024-03-06 | ||
| Formalized | 2024-03-06 | ||
| Pre-Assessment Letter Sent | 2024-03-21 | Retired Goods or Services | |
| Agent Name Changed | 2024-09-27 | ||
| Agent Name Changed | 2024-09-27 | ||
| Search Recorded | 2025-01-28 | ||
| Examiner's First Report | 2025-01-28 | 2025-07-28 | |
| Approved | 2025-06-11 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2025-06-11 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2025-08-27 | Vol.72 Issue 3696 | |
| Registration Pending | 2025-11-14 | ||
| Registered | 2025-11-14 | 2035-11-14 | |
| Agent Changed | 2026-04-21 | Transferred From: 2502 To: 59 |